↓ Skip to main content

Dove Medical Press

Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, February 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
26 Mendeley
Title
Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation
Published in
International Journal of Chronic Obstructive Pulmonary Disease, February 2020
DOI 10.2147/copd.s234760
Pubmed ID
Authors

Yanqiu Wu, Jiangyue Qin, Junyun He, Yongchun Shen, Hao Wang, Yanping Li, Qianglin Zeng, Jiajia Dong, Yunfei An, Shuguang Xiong, Mei Feng, Fuqiang Wen

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 19%
Researcher 3 12%
Student > Doctoral Student 2 8%
Lecturer 2 8%
Professor > Associate Professor 2 8%
Other 3 12%
Unknown 9 35%
Readers by discipline Count As %
Medicine and Dentistry 9 35%
Biochemistry, Genetics and Molecular Biology 3 12%
Nursing and Health Professions 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Agricultural and Biological Sciences 1 4%
Other 1 4%
Unknown 10 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2020.
All research outputs
#16,733,516
of 25,387,668 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#1,614
of 2,578 outputs
Outputs of similar age
#280,291
of 470,256 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#24
of 46 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,578 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 470,256 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.